The American Progress states that every 16 minutes, a person in America dies from an opioid overdose.
The War on Drugs began in June 1971 when U.S. President Richard Nixon declared drug abuse to be “public enemy number one” and increased federal funding for drug-control agencies and drug-treatment efforts.
Headaches are a major public health concern. Research states that CBD can desensitize the pain receptor and inhibit pathophysiological mechanism of headache.
Research has linked the inflammation-reducing characteristics of CBD, and its ability to eliminate excessive immune-related oxidative stress in order to allow the body to better heal itself, to significant symptom reduction in neuropathy patients, as well as being a safer choice of prescription medication.
One of the most overlooked benefits of CBD is its ability to combat drug and alcohol addiction. Research concludes that the brief 7-day period of CBD treatment not only prevented the development of previously displayed “addict-like” characteristics, it deterred the subject’s from relapsing for 5 months — even though the CBD cleared from the brain and body after 3 days.
CBD works with the endocannabinoid system works to maintain homeostasis by using cannabinoid receptors to monitor reactions in the body. When a discrepancy is detected, cannabinoids are synthesized to interact with receptors. Then they stimulate a chemical response to address the issue.
Studies have found that CBD helped to reduce inflammatory pain in rats by affecting the way that pain receptors respond to stimuli. The topical application of CBD had the potential to relieve pain and inflammation associated with arthritis.
Activation of cannabinoid receptors by endocannabinoids on epidermal cells regulates normal function of the skin as a barrier. When CB1 or CB2 are engaged, these functions of epidermal cells are modified – whether through proliferation, differentiation or apoptosis – which are all important processes for the healthy physical defense of the body. Endocannabinoids also suppress inflammation in the epidermis.
Cannabinoid receptor modulation controls the symptoms of nausea and vomiting. When cannabinoid receptor CB1 is stimulate, vomiting is suppressed.